208 related articles for article (PubMed ID: 35368696)
1. Integrative Analysis of the Expression Levels and Prognostic Values for NEK Family Members in Breast Cancer.
Gao WL; Niu L; Chen WL; Zhang YQ; Huang WH
Front Genet; 2022; 13():798170. PubMed ID: 35368696
[No Abstract] [Full Text] [Related]
2. Prognostic value and therapeutic potential of NEK family in stomach adenocarcinoma.
Zhou X; Nie H; Wang C; Yu X; Yang X; He X; Ou C
J Cancer; 2024; 15(10):3154-3172. PubMed ID: 38706902
[TBL] [Abstract][Full Text] [Related]
3. Potential Prognostic Biomarkers of NIMA (Never in Mitosis, Gene A)-Related Kinase (NEK) Family Members in Breast Cancer.
Anuraga G; Wang WJ; Phan NN; An Ton NT; Ta HDK; Berenice Prayugo F; Minh Xuan DT; Ku SC; Wu YF; Andriani V; Athoillah M; Lee KH; Wang CY
J Pers Med; 2021 Oct; 11(11):. PubMed ID: 34834441
[TBL] [Abstract][Full Text] [Related]
4. The NEK family of serine/threonine kinases as a biomarker for cancer.
Panchal NK; Evan Prince S
Clin Exp Med; 2023 Feb; 23(1):17-30. PubMed ID: 35037094
[TBL] [Abstract][Full Text] [Related]
5. Cell cycle regulation by the NEK family of protein kinases.
Fry AM; O'Regan L; Sabir SR; Bayliss R
J Cell Sci; 2012 Oct; 125(Pt 19):4423-33. PubMed ID: 23132929
[TBL] [Abstract][Full Text] [Related]
6. Expression of the NEK family in normal and cancer tissue: an immunohistochemical study.
Melo-Hanchuk TD; Martins MB; Cunha LL; Soares FA; Ward LS; Vassallo J; Kobarg J
BMC Cancer; 2020 Jan; 20(1):23. PubMed ID: 31906878
[TBL] [Abstract][Full Text] [Related]
7. Differential Expression of NEK Kinase Family Members in Esophageal Adenocarcinoma and Barrett's Esophagus.
Chen L; Ballout F; Lu H; Hu T; Zhu S; Chen Z; Peng D
Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835513
[TBL] [Abstract][Full Text] [Related]
8. Nek8, a NIMA family kinase member, is overexpressed in primary human breast tumors.
Bowers AJ; Boylan JF
Gene; 2004 Mar; 328():135-42. PubMed ID: 15019993
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive substrate specificity profiling of the human Nek kinome reveals unexpected signaling outputs.
van de Kooij B; Creixell P; van Vlimmeren A; Joughin BA; Miller CJ; Haider N; Simpson CD; Linding R; Stambolic V; Turk BE; Yaffe MB
Elife; 2019 May; 8():. PubMed ID: 31124786
[TBL] [Abstract][Full Text] [Related]
10. NEK Family Review and Correlations with Patient Survival Outcomes in Various Cancer Types.
Nguyen K; Boehling J; Tran MN; Cheng T; Rivera A; Collins-Burow BM; Lee SB; Drewry DH; Burow ME
Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046733
[TBL] [Abstract][Full Text] [Related]
11. Caught Nek-ing: cilia and centrioles.
Quarmby LM; Mahjoub MR
J Cell Sci; 2005 Nov; 118(Pt 22):5161-9. PubMed ID: 16280549
[TBL] [Abstract][Full Text] [Related]
12. The Mitochondrial Connection: The Nek Kinases' New Functional Axis in Mitochondrial Homeostasis.
Basei FL; E Silva IR; Dias PRF; Ferezin CC; Peres de Oliveira A; Issayama LK; Moura LAR; da Silva FR; Kobarg J
Cells; 2024 Mar; 13(6):. PubMed ID: 38534317
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the effect of NEKs on the prognosis of patients with non-small-cell lung carcinoma based on bioinformatics.
Yang M; Guo Y; Guo X; Mao Y; Zhu S; Wang N; Lu D
Sci Rep; 2022 Feb; 12(1):1705. PubMed ID: 35105934
[TBL] [Abstract][Full Text] [Related]
14. Prognostic values of SNAI family members in breast cancer patients.
Li D; Li L; Yang W; Chen L; Chen X; Wang Q; Hao B; Jin W; Cao Y
Ann Transl Med; 2020 Aug; 8(15):922. PubMed ID: 32953722
[TBL] [Abstract][Full Text] [Related]
15. Screening of novel biomarkers for breast cancer based on WGCNA and multiple machine learning algorithms.
Jin X; Huang Z; Guo P; Yuan R
Transl Cancer Res; 2023 Jun; 12(6):1466-1489. PubMed ID: 37434679
[TBL] [Abstract][Full Text] [Related]
16. Identification of Prognostic Biomarkers and Molecular Targets Among JAK Family in Breast Cancer.
Liu F; Wu H
J Inflamm Res; 2021; 14():97-114. PubMed ID: 33469338
[TBL] [Abstract][Full Text] [Related]
17. Integrative analysis of prognostic value and immune infiltration of spindle and kinetochore-associated family members in breast cancer.
Ding J; He X; Wang J; Cao G; Chen S; Yuan L; Chen B; Xiong M
Bioengineered; 2021 Dec; 12(2):10905-10923. PubMed ID: 34845974
[TBL] [Abstract][Full Text] [Related]
18. Screening of the novel immune-suppressive biomarkers of TMED family and whether knockdown of TMED2/3/4/9 inhibits cell migration and invasion in breast cancer.
Fang Z; Song YX; Wo GQ; Zhou HL; Li L; Yang SY; Chen X; Zhang J; Tang JH
Ann Transl Med; 2022 Dec; 10(23):1280. PubMed ID: 36618780
[TBL] [Abstract][Full Text] [Related]
19. Systematic analysis of the expression and prognosis relevance of FBXO family reveals the significance of FBXO1 in human breast cancer.
Liu Y; Pan B; Qu W; Cao Y; Li J; Zhao H
Cancer Cell Int; 2021 Feb; 21(1):130. PubMed ID: 33622332
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of the prognostic value and immune function of chemokine-CXC receptor family members in breast cancer.
Lyu L; Zheng Y; Hong Y; Wang M; Deng Y; Wu Y; Xu P; Yang S; Wang S; Yao J; Zhang D; Guo Y; Lyu J; Dai Z
Int Immunopharmacol; 2020 Oct; 87():106797. PubMed ID: 32702599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]